control group:Xuefu Zhuyu Jiaonang and Yangxin Dawaimixike Migao Simulant

2 trials

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences.

Conditions

wakefulness

Phase 4

Efficacy and Safety Evaluation of Yangxin Dawaimixike Migao in the Treatment of Insomnia (Qi Stagnation and Blood Stasis Syndrome): a block randomized, double-blind, double simulation, positive-controlled, multi-center clinical study

Active, not recruitingChiCTR2000029234

Guang'anmen Hospital, China Academy of Chinese Medical Sciences.wakefulness

Start: 2020-02-01Updated: 2020-01-20

Efficacy and Safety Evaluation of Yangxin Dawaimixike Migao in the Treatment of Insomnia (Qi Stagnation and Blood Stasis Syndrome): a block randomized, double-blind, double simulation, positive-contro

Active, not recruitingITMCTR2000002929

Guang'anmen Hospital, China Academy of Chinese Medical Sciences.wakefulness

Start: 2020-02-01Updated: 2023-02-20